Primed for resistance | Nature

A drug for treating melanoma is ineffective in colorectal cancers that have the same causative mutation. Studies of how cells adapt to the drug reveal why this is so, and suggest combination

therapies that may be more effective. SEE LETTER p.100 Access through your institution Buy or subscribe This is a preview of subscription content, access via your institution ACCESS OPTIONS

Access through your institution Subscribe to this journal Receive 51 print issues and online access $199.00 per year only $3.90 per issue Learn more Buy this article * Purchase on

SpringerLink * Instant access to full article PDF Buy now Prices may be subject to local taxes which are calculated during checkout ADDITIONAL ACCESS OPTIONS: * Log in * Learn about

institutional subscriptions * Read our FAQs * Contact customer support REFERENCES * Chapman, P. B. et al. _N. Engl. J. Med._ 364, 2507–2516 (2011). Article  CAS  Google Scholar  * Kopetz, S.

et al. _J. Clin. Oncol._ 28 (ASCO Meet. Abstr. Pt 1), abstr. 3534 (2010). * Prahallad, A. et al. _Nature_ 483, 100–103 (2012). Article  ADS  CAS  Google Scholar  * Poulikakos, P. I., Zhang,

C., Bollag, G., Shokat, K. M. & Rosen, N. _Nature_ 464, 427–430 (2010). Article  ADS  CAS  Google Scholar  * Nazarian, R. et al. _Nature_ 468, 973–977 (2010). Article  ADS  CAS  Google

Scholar  * Poulikakos, P. I. et al. _Nature_ 480, 387–390 (2011). Article  ADS  CAS  Google Scholar  * Corcoran, R. B. et al. _Cancer Discov._ http://dx.doi.org/10.1158/2159-8290.CD-11-0341

(2012). * Di Nicolantonio, F. et al. _J. Clin. Oncol._ 26, 5705–5712 (2008). Article  CAS  Google Scholar  * Joseph, E. W. et al. _Proc. Natl Acad. Sci. USA_ 107, 14903–14908 (2010). Article

  ADS  CAS  Google Scholar  * Oberholzer, P. A. et al. _J. Clin. Oncol._ 30, 316–321 (2012). Article  CAS  Google Scholar  * Su, F. et al. _N. Engl. J. Med._ 366, 207–215 (2012). Article 

CAS  Google Scholar  * Infante, J. R. et al. _J. Clin. Oncol._ 29 (ASCO Meet. Abstr. Pt 1), abstr. CRA8503 (2011). Download references AUTHOR INFORMATION AUTHORS AND AFFILIATIONS * David B.

Solit is in the Department of Medicine and the Human Oncology and Pathogenesis Program, Memorial Sloan-Kettering Cancer Center, New York, New York 10065, USA., David B. Solit * Pasi A. Jänne

is at the Lowe Center for Thoracic Oncology, Dana Farber Cancer Institute, Boston, Massachusetts 02215, USA., Pasi A. Jänne Authors * David B. Solit View author publications You can also

search for this author inPubMed Google Scholar * Pasi A. Jänne View author publications You can also search for this author inPubMed Google Scholar CORRESPONDING AUTHORS Correspondence to

David B. Solit or Pasi A. Jänne. RIGHTS AND PERMISSIONS Reprints and permissions ABOUT THIS ARTICLE CITE THIS ARTICLE Solit, D., Jänne, P. Primed for resistance. _Nature_ 483, 44–45 (2012).

https://doi.org/10.1038/483044a Download citation * Published: 29 February 2012 * Issue Date: 01 March 2012 * DOI: https://doi.org/10.1038/483044a SHARE THIS ARTICLE Anyone you share the

following link with will be able to read this content: Get shareable link Sorry, a shareable link is not currently available for this article. Copy to clipboard Provided by the Springer

Nature SharedIt content-sharing initiative